Liver Intra-Arterial Prrt with 111in-Octreotide: The Tumoricidal Efficacy of 111in Auger Electron Emission

Georgios S. Limouris is a Nuclear Physician and Professor of Nuclear Medicine at the National and Kapodistrian University of Athens (NKUA). After beginning his medical studies at the Vienna University Medical School in 1967, he continued in Greece and received his MD from the NKUA in 1972 and his PhD (Habilitation) in 1974. A lecturer at the NKUA since 1989, he organized together with other colleagues annual Mediterranean Meetings for more than a decade, covering virtually all hot topics in Nuclear Medicine in a 13-volume series (Mediterra Publishers). Prof. Limouris is Vice-President of the Examination Committee for the specialty ＂Nuclear Medicine＂ and the Executive-Committee for ＂Radiopharmaceuticals,＂ a member of the Editorial Board of the EJNMMI, and an Associate Editor of the Journal Frontiers in Oncology for Cancer Imaging and Diagnosis.

Prof. Limouris is the author of over 300 publications. Since 1997 he has intensively promoted Peptide Receptor Radionuclide Therapy in Greece, using Indium-111-pentetreotide almost exclusively intra-arterially. To date he has performed more than 1000 infusions, using an invention of his own dubbed the ＂Aretaieion Protocol＂ [Q J Nucl Med Mol Imaging, Nov-2012]. For his scientific contributions, in 2015 he was awarded the title of Scientific Advisor for Nuclear Medicine by ＂Aretaieion＂ University Hospital.